Compare ALEMBIC with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs AJANTA PHARMA - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC AJANTA PHARMA ALEMBIC/
AJANTA PHARMA
 
P/E (TTM) x 79.5 28.2 282.1% View Chart
P/BV x 6.9 7.8 87.5% View Chart
Dividend Yield % 0.1 0.5 33.1%  

Financials

 ALEMBIC   AJANTA PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-18
AJANTA PHARMA
Mar-19
ALEMBIC/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs721,422 5.1%   
Low Rs34898 3.8%   
Sales per share (Unadj.) Rs4.7233.5 2.0%  
Earnings per share (Unadj.) Rs6.144.0 13.9%  
Cash flow per share (Unadj.) Rs6.252.2 12.0%  
Dividends per share (Unadj.) Rs0.209.00 2.2%  
Dividend yield (eoy) %0.40.8 48.7%  
Book value per share (Unadj.) Rs40.7255.1 15.9%  
Shares outstanding (eoy) m267.0388.02 303.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x11.35.0 226.8%   
Avg P/E ratio x8.726.4 32.9%  
P/CF ratio (eoy) x8.522.2 38.1%  
Price / Book Value ratio x1.34.5 28.6%  
Dividend payout %3.320.5 16.0%   
Avg Mkt Cap Rs m14,139102,081 13.9%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m2074,307 4.8%   
Avg. sales/employee Rs ThNM3,022.6-  
Avg. wages/employee Rs ThNM633.4-  
Avg. net profit/employee Rs ThNM569.1-  
INCOME DATA
Net Sales Rs m1,25520,554 6.1%  
Other income Rs m370211 175.6%   
Total revenues Rs m1,62520,765 7.8%   
Gross profit Rs m1115,664 2.0%  
Depreciation Rs m38721 5.2%   
Interest Rs m212 14.7%   
Profit before tax Rs m4425,143 8.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,273 1.9%   
Profit after tax Rs m1,6303,870 42.1%  
Gross profit margin %8.927.6 32.1%  
Effective tax rate %5.424.8 21.9%   
Net profit margin %129.818.8 689.7%  
BALANCE SHEET DATA
Current assets Rs m1,86711,812 15.8%   
Current liabilities Rs m5913,776 15.7%   
Net working cap to sales %101.639.1 260.0%  
Current ratio x3.23.1 101.0%  
Inventory Days Days9477 121.8%  
Debtors Days Days7482 90.1%  
Net fixed assets Rs m1,79114,398 12.4%   
Share capital Rs m534175 304.5%   
"Free" reserves Rs m10,32422,277 46.3%   
Net worth Rs m10,85822,452 48.4%   
Long term debt Rs m417 624.2%   
Total assets Rs m11,59126,962 43.0%  
Interest coverage x260.9444.3 58.7%   
Debt to equity ratio x00 1,290.8%  
Sales to assets ratio x0.10.8 14.2%   
Return on assets %14.114.4 97.8%  
Return on equity %15.017.2 87.1%  
Return on capital %15.223.0 66.2%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1910,682 0.2%   
Fx outflow Rs m2642,102 12.6%   
Net fx Rs m-2448,580 -2.8%   
CASH FLOW
From Operations Rs m2363,748 6.3%  
From Investments Rs m-224-2,228 10.1%  
From Financial Activity Rs m-27-1,475 1.8%  
Net Cashflow Rs m-1545 -32.7%  

Share Holding

Indian Promoters % 64.0 73.8 86.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 1.6 12.9%  
FIIs % 9.7 7.6 127.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 17.0 153.5%  
Shareholders   54,701 20,968 260.9%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   CIPLA  PFIZER  NATCO PHARMA  SHASUN PHARMA  SANOFI INDIA  

Compare ALEMBIC With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 6, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS